Analyzing serum-stimulated prostate cancer cell lines after low-fat, high-fiber diet and exercise intervention

Sherry Soliman1, William J Aronson, R James Barnard

  • 1Department of Physiological Science, University of California, Los Angeles, CA 90095, USA.

Insights

A low-fat, high-fiber diet and exercise intervention showed potential in slowing prostate cancer (PCa) growth and increasing cancer cell death. Adding insulin-like growth factor-I (IGF-I) reversed these beneficial effects, suggesting IGF-I is a key mediator.

Area of Science:

  • Oncology
  • Endocrinology
  • Nutrition Science

Background:

  • Lifestyle interventions, including diet and exercise, are explored for prostate cancer (PCa) prevention and treatment.
  • Previous studies indicated serum from men on such interventions reduced growth and increased apoptosis in prostate cancer cells, linked to reduced insulin-like growth factor-I (IGF-I).

Purpose of the Study:

  • To elucidate the specific mechanisms by which diet and exercise interventions exert anticancer effects on prostate cancer cells.
  • To investigate the role of IGF-I in mediating the observed effects of lifestyle interventions.

Main Methods:

  • Utilized androgen-dependent LNCaP and androgen-independent PC-3 prostate cancer cell lines.
  • Applied serum from men before and after a low-fat, high-fiber diet and exercise intervention.
  • Investigated the impact of adding back IGF-I to post-intervention serum and blocking the IGF-I receptor.

Main Results:

  • The intervention slowed LNCaP cell growth and increased apoptosis, effects abolished by adding IGF-I.
  • Intervention led to increased p53 protein content and reduced NFκB activation in LNCaP cells.
  • IGF-I receptor blockade mimicked the intervention's effects on LNCaP cells; PC-3 cell growth was reduced without other changes.

Conclusions:

  • Diet and exercise interventions may inhibit prostate cancer progression by modulating IGF-I signaling pathways.
  • These findings suggest lifestyle interventions could be valuable in preventing and treating early-stage prostate cancer.